Journal Home
Search for

Volume 88, Issue 1, Pages 240-243 (July 2007)


View previous. 45 of 56 View next.

The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study

Presented at the ASRM 62nd Annual Meeting, New Orleans, Louisiana, October 21, 2006.

Jeff G. Wang, M.D.aCorresponding Author Informationemail address, Richard A. Anderson, Ph.D.b, George M. Graham III, M.D.c, Micheline C. Chu, M.D.a, Mark V. Sauer, M.D.a, Michael M. Guarnaccia, M.D.a, Rogerio A. Lobo, M.D.a

Received 27 July 2006; received in revised form 1 November 2006; accepted 16 November 2006. published online 12 February 2007.

Cinnamon extract has been shown to reduce insulin resistance in in vitro and in vivo studies by increasing phosphatidylinositol 3-kinase activity in the insulin signaling pathway and thus potentiating insulin action. Fifteen women with polycystic ovary syndrome (PCOS) were randomized to daily oral cinnamon and placebo for 8 weeks. Comparisons of post-treatment to baseline insulin sensitivity indices using fasting and 2-hour oral glucose tolerance tests showed significant reductions in insulin resistance in the cinnamon group but not in the placebo group. A larger trial is needed to confirm the findings of this pilot study and to evaluate the effect of cinnamon extract on menstrual cyclicity.

a Department of Obstetrics & Gynecology, Division of Reproductive Endocrinology, College of Physicians & Surgeons, Columbia University, New York, New York

b US Department of Agriculture, Agriculture Research Service, Beltsville Human Nutrition Research Center, Beltsville, Maryland

c Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii

Corresponding Author InformationReprint requests: Jeff Wang, M.D., Department of Obstetrics & Gynecology, Columbia University, 622 W. 168th Street PH-16, New York, NY 10023 (FAX: 212-305.4326).

PII: S0015-0282(06)04555-9

doi:10.1016/j.fertnstert.2006.11.082


View previous. 45 of 56 View next.